Intelligence · Clinical Development
Pipeline search results
Programs matching “nivolumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 40 pipeline programs matching "nivolumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Nivolumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Biliary Tract Cancer(BTC)
1 trial -
Nivolumab & Ipilimumab
The First People's Hospital of Lianyungang
Lung Cancer - Non Small Cell
1 trial -
Nivolumab Injection [Opdivo]
The First People's Hospital of Lianyungang
Neoplasms
1 trial -
ivosidenib and nivolumab
Agios Netherlands B.V.
Advanced Solid Tumor
1 trial -
nivolumab
Bristol-Myers Squibb
Neoplasms by Site
1 trial -
nivolumab, ipilimumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma (HCC)
1 trial -
BBP-398 with nivolumab
BridgeBio Oncology Therapeutics
Non Small Cell Lung Cancer
1 trial -
Nivolumab
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial -
Nivolumab
Jazz Pharmaceuticals Ireland Limited
Small-cell Lung Cancer
1 trial -
Nivolumab
Atrium Therapeutics
Brain and Nervous System
1 trial -
Nivolumab
Bristol-Myers Squibb
Melanoma
1 trial -
Nivolumab
Iovance Biotherapeutics B.V.
Melanoma (Skin)
1 trial -
Nivolumab
Iovance Biotherapeutics B.V.
Non-Small Cell Lung Cancer
1 trial -
Nivolumab
Nektar Therapeutics UK Limited
Renal Cell Carcinoma
1 trial -
Nivolumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect of Drug
1 trial -
NIVOLUMAB
Disc Medicine
Melanoma, Renal cell carcinoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.